Ercros SA

Ercros SA operates with a market capitalization of EUR 311.8 million and a price-to-book ratio of 1.09, indicating a valuation close to its book value. The company's liquidity position is characterized by EUR 96.0 million in cash and equivalents, but its long-term debt of EUR 223.1 million results in a debt-to-equity ratio of 0.78, suggesting moderate leverage. The current ratio of 1.15 indicates a relatively stable short-term liquidity position, though not robust. Profitability metrics reveal a challenging financial situation. The company reported a net loss of EUR 53.6 million and an operating loss of EUR 28.1 million, resulting in a negative return on equity of -18.65% and a negative return on assets of -7.72%. These figures are below the typical performance of the Commodity Chemicals industry, which usually exhibits more stable returns due to the nature of its products and demand. Ercros' revenue is distributed across three business lines: Businesses Associated to Chlorine, Intermediate Chemicals, and Pharmaceuticals. The Chlorine segment is the most significant, with products including chlorine, caustic soda, and PVC. The company's geographic exposure is primarily within Spain, with subsidiaries in various locations, but the input data does not provide specific revenue concentration by region or segment. The company's growth trajectory is uncertain. Analysts estimate a revenue of EUR 662.8 million for the current fiscal year, a modest increase from the actual EUR 626.8 million reported. However, the operating income is expected to remain negative, with an estimated EBIT of EUR -15.8 million. The free cash flow of EUR -30.3 million indicates that the company is not generating sufficient cash to fund operations and capital expenditures without external financing. Risk factors include a negative net cash position after subtracting total debt, which could limit the company's ability to respond to market fluctuations. The dilution risk is assessed as low, but the company's negative earnings and cash flow could necessitate future equity issuance, potentially diluting existing shareholders. The market data ESG controversies score of 100.0 indicates significant environmental, social, and governance (ESG) risks, which could affect the company's reputation and regulatory compliance. Recent events include the sale of Fosfatos de Cartagena SLU to Timab Iberica in April 2014, which may have impacted the company's asset base and operational focus. The company's recent financial performance, as reflected in the negative EPS of EUR -0.59 and the mean EPS estimate of EUR -0.25, suggests ongoing operational challenges.